TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A.

Karen L Reckamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.